MHRA reclassifies several drugs
This article was originally published in The Tan Sheet
Executive Summary
The U.K. Medicines and Healthcare products Regulatory Agency eases restrictions on several medicines, including switching to nonprescription sale alclometasone dipropionate 0.05 percent for the short-term treatment of eczema and dermatitis in consumers 12 years and older. The agency also will allow the general sale (equivalent to OTC in the U.S.) of terbinafine hydrochloride 1 percent cutaneous solution for the treatment of tinea pedis in consumers 18 and older, and a combination pack of 2 mg nicotine gum and nicotine patches that release 15 mg over 16 hours for smoking cessation. Finally, the agency doubles the maximum pack size of the allergy relief medicine loratadine 10 mg available for general sale from seven tablets to 14 tablets